Zobrazeno 1 - 10
of 109
pro vyhledávání: '"T. Kepak"'
Autor:
A. J. M. Meijer, F. A. Diepstraten, T. Langer, L. Broer, I. K. Domingo, E. Clemens, A. G. Uitterlinden, A. C. H. de Vries, M. van Grotel, W. P. Vermeij, R. A. Ozinga, H. Binder, J. Byrne, E. van Dulmen-den Broeder, M. L. Garrè, D. Grabow, P. Kaatsch, M. Kaiser, L. Kenborg, J. F. Winther, C. Rechnitzer, H. Hasle, T. Kepak, K. Kepakova, W. J. E. Tissing, A. L. F. van der Kooi, L. C. M. Kremer, J. Kruseova, S. M. F. Pluijm, C. E. Kuehni, H. J. H. van der Pal, R. Parfitt, C. Spix, A. Tillmanns, D. Deuster, P. Matulat, G. Calaminus, A. E. Hoetink, S. Elsner, J. Gebauer, R. Haupt, H. Lackner, C. Blattmann, S. J. C. M. M. Neggers, S. R. Rassekh, G. E. B. Wright, B. Brooks, A. P. Nagtegaal, B. I. Drögemöller, C. J. D. Ross, A. P. Bhavsar, A. G. am Zehnhoff-Dinnesen, B. C. Carleton, O. Zolk, M. M. van den Heuvel-Eibrink, the PanCareLIFE Consortium, and the CPNDS Consortium
Publikováno v:
npj Precision Oncology, Vol 5, Iss 1, Pp 1-8 (2021)
Abstract In children with cancer, the heterogeneity in ototoxicity occurrence after similar treatment suggests a role for genetic susceptibility. Using a genome-wide association study (GWAS) approach, we identified a genetic variant in TCERG1L (rs893
Externí odkaz:
https://doaj.org/article/1a21ee1f4f0440f184693f4b2b482abf
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Wim J. E. Tissing, J Kruseova, A E Hoetink, G Calaminus, R Haupt, I K Domingo, E van Dulmen-den Broeder, Amit P. Bhavsar, J Byrne, H Hasle, C Spix, S Elsner, A P Nagtegaal, L Kenborg, J Gebauer, O Zolk, S M F Pluijm, A J M Meijer, H Binder, R A Ozinga, C Rechnitzer, S J C M M Neggers, M L Garrè, P Matulat, D Deuster, T Langer, Britt I. Drögemöller, H. J. H. van der Pal, D Grabow, Leontien C. M. Kremer, Galen E.B. Wright, E Clemens, A.L.F. van der Kooi, M Kaiser, Bruce Carleton, F A Diepstraten, J F Winther, C Blattmann, L Broer, M van Grotel, R Parfitt, A G Am Zehnhoff-Dinnesen, K Kepakova, H Lackner, M M van den Heuvel-Eibrink, Shahrad Rod Rassekh, T Kepak, A. C. H. de Vries, Beth Brooks, André G. Uitterlinden, C. E. Kuehni, A Tillmanns, Wilbert P. Vermeij, Colin J. D. Ross, P Kaatsch
Publikováno v:
37. Wissenschaftliche Jahrestagung der Deutschen Gesellschaft für Phoniatrie und Pädaudiologie (DGPP); 20210917-20210918; sine loco [digital]; DOCP15 /20211028/
The PanCareLIFE Consortium & and the CPNDS Consortium 2021, ' TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study ', npj Precision Oncology, vol. 5, no. 1, 64 . https://doi.org/10.1038/s41698-021-00178-z
Meijer, A J M, Diepstraten, F A, Langer, T, Broer, L, Domingo, I K, Clemens, E, Uitterlinden, A G, de Vries, A C H, van Grotel, M, Vermeij, W P, Ozinga, R A, Binder, H, Byrne, J, van Dulmen-den Broeder, E, Garrè, M L, Grabow, D, Kaatsch, P, Kaiser, M, Kenborg, L, Winther, J F, Rechnitzer, C, Hasle, H, Kepak, T, Kepakova, K, Tissing, W J E, van der Kooi, A L F, Kremer, L C M, Kruseova, J, Pluijm, S M F, Kuehni, C E, van der Pal, H J H, Parfitt, R, Spix, C, Tillmanns, A, Deuster, D, Matulat, P, Calaminus, G, Hoetink, A E, Elsner, S, Gebauer, J, Haupt, R, Lackner, H, Blattmann, C, Neggers, S J C M M, Rassekh, S R, Wright, G E B, Brooks, B, Nagtegaal, A P, Drögemöller, B I, Ross, C J D, The PanCareLIFE consortium & and the CPNDS Consortium 2021, ' TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study ', npj Precision Oncology, vol. 5, no. 1, 64 . https://doi.org/10.1038/s41698-021-00178-z
Meijer, A J M, Diepstraten, F A, Langer, T, Broer, L, Domingo, I K, Clemens, E, Uitterlinden, A G, de Vries, A C H, van Grotel, M, Vermeij, W P, Ozinga, R A, Binder, H, Byrne, J, van Dulmen-den Broeder, E, Garrè, M L, Grabow, D, Kaatsch, P, Kaiser, M, Kenborg, L, Winther, J F, Rechnitzer, C, Hasle, H, Kepak, T, Kepakova, K, Tissing, W J E, van der Kooi, A L F, Kremer, L C M, Kruseova, J, Pluijm, S M F, Kuehni, C E, van der Pal, H J H, Parfitt, R, Spix, C, Tillmanns, A, Deuster, D, Matulat, P, Calaminus, G, Hoetink, A E, Elsner, S, Gebauer, J, Haupt, R, Lackner, H, Blattmann, C, Neggers, S J C M M, Rassekh, S R, Wright, G E B, Brooks, B, Nagtegaal, A P, Drögemöller, B I, Ross, C J D, the PanCareLIFE Consortium & and the CPNDS Consortium 2021, ' TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study ', npj Precision Oncology, vol. 5, 64 . https://doi.org/10.1038/s41698-021-00178-z
npj Precision Oncology, 5(1):64. Springer Nature
Meijer, A J M; Diepstraten, F A; Langer, T; Broer, L; Domingo, I K; Clemens, E; Uitterlinden, A G; de Vries, A C H; van Grotel, M; Vermeij, W P; Ozinga, R A; Binder, H; Byrne, J; van Dulmen-den Broeder, E; Garrè, M L; Grabow, D; Kaatsch, P; Kaiser, M; Kenborg, L; Winther, J F; ... (2021). TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study. NPJ precision oncology, 5(1), p. 64. Springer Nature 10.1038/s41698-021-00178-z
NPJ Precision Oncology
NPJ precision oncology, 5(1):64, 1-8. Nature Research
npj Precision Oncology, Vol 5, Iss 1, Pp 1-8 (2021)
The PanCareLIFE Consortium & and the CPNDS Consortium 2021, ' TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study ', npj Precision Oncology, vol. 5, no. 1, 64 . https://doi.org/10.1038/s41698-021-00178-z
Meijer, A J M, Diepstraten, F A, Langer, T, Broer, L, Domingo, I K, Clemens, E, Uitterlinden, A G, de Vries, A C H, van Grotel, M, Vermeij, W P, Ozinga, R A, Binder, H, Byrne, J, van Dulmen-den Broeder, E, Garrè, M L, Grabow, D, Kaatsch, P, Kaiser, M, Kenborg, L, Winther, J F, Rechnitzer, C, Hasle, H, Kepak, T, Kepakova, K, Tissing, W J E, van der Kooi, A L F, Kremer, L C M, Kruseova, J, Pluijm, S M F, Kuehni, C E, van der Pal, H J H, Parfitt, R, Spix, C, Tillmanns, A, Deuster, D, Matulat, P, Calaminus, G, Hoetink, A E, Elsner, S, Gebauer, J, Haupt, R, Lackner, H, Blattmann, C, Neggers, S J C M M, Rassekh, S R, Wright, G E B, Brooks, B, Nagtegaal, A P, Drögemöller, B I, Ross, C J D, The PanCareLIFE consortium & and the CPNDS Consortium 2021, ' TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study ', npj Precision Oncology, vol. 5, no. 1, 64 . https://doi.org/10.1038/s41698-021-00178-z
Meijer, A J M, Diepstraten, F A, Langer, T, Broer, L, Domingo, I K, Clemens, E, Uitterlinden, A G, de Vries, A C H, van Grotel, M, Vermeij, W P, Ozinga, R A, Binder, H, Byrne, J, van Dulmen-den Broeder, E, Garrè, M L, Grabow, D, Kaatsch, P, Kaiser, M, Kenborg, L, Winther, J F, Rechnitzer, C, Hasle, H, Kepak, T, Kepakova, K, Tissing, W J E, van der Kooi, A L F, Kremer, L C M, Kruseova, J, Pluijm, S M F, Kuehni, C E, van der Pal, H J H, Parfitt, R, Spix, C, Tillmanns, A, Deuster, D, Matulat, P, Calaminus, G, Hoetink, A E, Elsner, S, Gebauer, J, Haupt, R, Lackner, H, Blattmann, C, Neggers, S J C M M, Rassekh, S R, Wright, G E B, Brooks, B, Nagtegaal, A P, Drögemöller, B I, Ross, C J D, the PanCareLIFE Consortium & and the CPNDS Consortium 2021, ' TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study ', npj Precision Oncology, vol. 5, 64 . https://doi.org/10.1038/s41698-021-00178-z
npj Precision Oncology, 5(1):64. Springer Nature
Meijer, A J M; Diepstraten, F A; Langer, T; Broer, L; Domingo, I K; Clemens, E; Uitterlinden, A G; de Vries, A C H; van Grotel, M; Vermeij, W P; Ozinga, R A; Binder, H; Byrne, J; van Dulmen-den Broeder, E; Garrè, M L; Grabow, D; Kaatsch, P; Kaiser, M; Kenborg, L; Winther, J F; ... (2021). TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study. NPJ precision oncology, 5(1), p. 64. Springer Nature 10.1038/s41698-021-00178-z
NPJ Precision Oncology
NPJ precision oncology, 5(1):64, 1-8. Nature Research
npj Precision Oncology, Vol 5, Iss 1, Pp 1-8 (2021)
Background: Ototoxicity (hearing loss, tinnitus and/or vertigo) is a serious adverse event of cisplatin treatment in children with cancer. The heterogeneity in ototoxicity occurrence after similar treatment suggests a role for genetic susceptibility.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87b1abb74a67b5c6ca531ead07151865
http://www.egms.de/en/meetings/dgpp2021/21dgpp30.shtml
http://www.egms.de/en/meetings/dgpp2021/21dgpp30.shtml
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Julianne Byrne, Desiree Grabow, Helen Campbell, Kylie O'Brien, Stefan Bielack, Antoinette am Zehnhoff-Dinnesen, Gabriele Calaminus, Leontien Kremer, Thorsten Langer, Marry M. van den Heuvel-Eibrink, Eline van Dulmen-den Broeder, Katja Baust, Andrea Bautz, Jörn D. Beck, Claire Berger, Harald Binder, Anja Borgmann-Staudt, Linda Broer, Holger Cario, Leonie Casagranda, Eva Clemens, Dirk Deuster, Andrica de Vries, Uta Dirksen, Jeanette Falck Winther, Sophie Fosså, Anna Font-Gonzalez, Victoria Grandage, Riccardo Haupt, Stefanie Hecker-Nolting, Lars Hjorth, Melanie Kaiser, Line Kenborg, Tomas Kepak, Kateřina Kepáková, Lisbeth E. Knudsen, Maryna Krawczuk-Rybak, Jarmila Kruseova, Claudia E. Kuehni, Marina Kunstreich, Rahel Kuonen, Herwig Lackner, Alison Leiper, Erik A.H. Loeffen, Ales Luks, Dalit Modan-Moses, Renee Mulder, Ross Parfitt, Norbert W. Paul, Andreas Ranft, Ellen Ruud, Ralph Schilling, Claudia Spix, Joanna Stefanowicz, Gabriele Strauβ, Andre G. Uitterlinden, Marleen van den Berg, Anne-Lotte van der Kooi, Marloes van Dijk, Flora van Leeuwen, Oliver Zolk, Daniela Zöller, Peter Kaatsch, P. Kaatsch, D. Grabow, J. Byrne, H. Campbell, C. Clissmann, K. O'Brien, L.C.M. Kremer, T. Langer, E. van Dulmen-den Broeder, Dr. MH. van den Berg, M.M. van den Heuvel-Eibrink, A. Borgmann-Staudt, A. am Zehnhoff-Dinnesen, C.E. Kuehni, R. Haupt, T. Kepak, C. Berger, J.F. Winther, J. Kruseova, G. Calaminus, K. Baust, U. Dirksen, F. van Leeuwen, R. Schilling, G. Strauss, A. Ranft, M.-L. Garré, S. Fosså, A. Leiper, H. Lackner, A. Panasiuk, Dr. M. Krawczuk-Rybak, M. Kunstreich, H. Cario, O. Zolk, S. Bielack, J. Stefanowicz, V. Grandage, D. Modan
Publikováno v:
European journal of cancer (Oxford, England, 103, 227-237. Elsevier Limited
European Journal of Cancer, 103, 227-237. Elsevier Ltd.
European Journal of Cancer, 103, 227-237. Pergamon
Byrne, J, Grabow, D, Campbell, H, O'Brien, K, Bielack, S, am Zehnhoff-Dinnesen, A, Calaminus, G, Kremer, L, Langer, T, van den Heuvel-Eibrink, M M, van Dulmen-den Broeder, E, Baust, K, Bautz, A, Beck, J R D, Berger, C, Binder, H, Borgmann-Staudt, A, Broer, L, Cario, H, Casagranda, L, Clemens, E, Deuster, D, de Vries, A, Dirksen, U, Falck Winther, J, Fosså, S, Font-Gonzalez, A, Grandage, V, Haupt, R, Hecker-Nolting, S, Hjorth, L, Kaiser, M, Kenborg, L, Kepak, T, Kepáková, K, Knudsen, L E, Krawczuk-Rybak, M, Kruseova, J, Kuehni, C E, Kunstreich, M, Kuonen, R, Lackner, H, Leiper, A, Loeffen, E A H, Luks, A, Modan-Moses, D, Mulder, R, Parfitt, R, Paul, N W, Ranft, A, Ruud, E, Schilling, R, Spix, C, Stefanowicz, J, Strauβ, G, Uitterlinden, A G, van den Berg, M, van der Kooi, A-L, van Dijk, M, van Leeuwen, F, Zolk, O, Zöller, D, Kaatsch, P, Kaatsch, P, Grabow, D, Byrne, J, Campbell, H, Clissmann, C, O'Brien, K, Kremer, L C M, Langer, T, van Dulmen-den Broeder, E, van den Berg, D M H, van den Heuvel-Eibrink, M M, Borgmann-Staudt, A, am Zehnhoff-Dinnesen, A, Kuehni, C E, Haupt, R, Kepak, T, Berger, C, Winther, J F, Kruseova, J, Calaminus, G, Baust, K, Dirksen, U, van Leeuwen, F, Schilling, R, Strauss, G, Ranft, A, Garré, M L, Berger, C, Fosså, S, Leiper, A, Lackner, H, Panasiuk, A, Krawczuk-Rybak, D M, Kunstreich, M, Cario, H, Zolk, O, Bielack, S, Stefanowicz, J, Grandage, V, Modan, D, Paul, N W & Knudsen, L E 2018, ' PanCareLIFE: The scientific basis for a European project to improve long-term care regarding fertility, ototoxicity and health-related quality of life after cancer occurring among children and adolescents ', European Journal of Cancer, vol. 103, pp. 227-237 . https://doi.org/10.1016/j.ejca.2018.08.007
Byrne, J, Grabow, D, Campbell, H, O'Brien, K, Bielack, S, Am Zehnhoff-Dinnesen, A, Calaminus, G, Kremer, L, Langer, T, van den Heuvel-Eibrink, M M, van Dulmen-den Broeder, E, Baust, K, Bautz, A, Beck, J D, Berger, C, Binder, H, Borgmann-Staudt, A, Broer, L, Cario, H, Casagranda, L, Clemens, E, Deuster, D, de Vries, A, Dirksen, U, Falck Winther, J, Fosså, S, Font-Gonzalez, A, Grandage, V, Haupt, R, Hecker-Nolting, S, Hjorth, L, Kaiser, M, Kenborg, L, Kepak, T, Kepáková, K, Knudsen, L E, Krawczuk-Rybak, M, Kruseova, J, Kuehni, C E, Kunstreich, M, Kuonen, R, Lackner, H, Leiper, A, Loeffen, E A H, Luks, A, Modan-Moses, D, Mulder, R & PanCareLIFE Consortium 2018, ' PanCareLIFE : The scientific basis for a European project to improve long-term care regarding fertility, ototoxicity and health-related quality of life after cancer occurring among children and adolescents ', European journal of cancer (Oxford, England : 1990), vol. 103, pp. 227-237 . https://doi.org/10.1016/j.ejca.2018.08.007
European Journal of Cancer, 103, 227-237. ELSEVIER SCI LTD
European Journal of Cancer, 103, 227-237. Elsevier Ltd.
European Journal of Cancer, 103, 227-237. Pergamon
Byrne, J, Grabow, D, Campbell, H, O'Brien, K, Bielack, S, am Zehnhoff-Dinnesen, A, Calaminus, G, Kremer, L, Langer, T, van den Heuvel-Eibrink, M M, van Dulmen-den Broeder, E, Baust, K, Bautz, A, Beck, J R D, Berger, C, Binder, H, Borgmann-Staudt, A, Broer, L, Cario, H, Casagranda, L, Clemens, E, Deuster, D, de Vries, A, Dirksen, U, Falck Winther, J, Fosså, S, Font-Gonzalez, A, Grandage, V, Haupt, R, Hecker-Nolting, S, Hjorth, L, Kaiser, M, Kenborg, L, Kepak, T, Kepáková, K, Knudsen, L E, Krawczuk-Rybak, M, Kruseova, J, Kuehni, C E, Kunstreich, M, Kuonen, R, Lackner, H, Leiper, A, Loeffen, E A H, Luks, A, Modan-Moses, D, Mulder, R, Parfitt, R, Paul, N W, Ranft, A, Ruud, E, Schilling, R, Spix, C, Stefanowicz, J, Strauβ, G, Uitterlinden, A G, van den Berg, M, van der Kooi, A-L, van Dijk, M, van Leeuwen, F, Zolk, O, Zöller, D, Kaatsch, P, Kaatsch, P, Grabow, D, Byrne, J, Campbell, H, Clissmann, C, O'Brien, K, Kremer, L C M, Langer, T, van Dulmen-den Broeder, E, van den Berg, D M H, van den Heuvel-Eibrink, M M, Borgmann-Staudt, A, am Zehnhoff-Dinnesen, A, Kuehni, C E, Haupt, R, Kepak, T, Berger, C, Winther, J F, Kruseova, J, Calaminus, G, Baust, K, Dirksen, U, van Leeuwen, F, Schilling, R, Strauss, G, Ranft, A, Garré, M L, Berger, C, Fosså, S, Leiper, A, Lackner, H, Panasiuk, A, Krawczuk-Rybak, D M, Kunstreich, M, Cario, H, Zolk, O, Bielack, S, Stefanowicz, J, Grandage, V, Modan, D, Paul, N W & Knudsen, L E 2018, ' PanCareLIFE: The scientific basis for a European project to improve long-term care regarding fertility, ototoxicity and health-related quality of life after cancer occurring among children and adolescents ', European Journal of Cancer, vol. 103, pp. 227-237 . https://doi.org/10.1016/j.ejca.2018.08.007
Byrne, J, Grabow, D, Campbell, H, O'Brien, K, Bielack, S, Am Zehnhoff-Dinnesen, A, Calaminus, G, Kremer, L, Langer, T, van den Heuvel-Eibrink, M M, van Dulmen-den Broeder, E, Baust, K, Bautz, A, Beck, J D, Berger, C, Binder, H, Borgmann-Staudt, A, Broer, L, Cario, H, Casagranda, L, Clemens, E, Deuster, D, de Vries, A, Dirksen, U, Falck Winther, J, Fosså, S, Font-Gonzalez, A, Grandage, V, Haupt, R, Hecker-Nolting, S, Hjorth, L, Kaiser, M, Kenborg, L, Kepak, T, Kepáková, K, Knudsen, L E, Krawczuk-Rybak, M, Kruseova, J, Kuehni, C E, Kunstreich, M, Kuonen, R, Lackner, H, Leiper, A, Loeffen, E A H, Luks, A, Modan-Moses, D, Mulder, R & PanCareLIFE Consortium 2018, ' PanCareLIFE : The scientific basis for a European project to improve long-term care regarding fertility, ototoxicity and health-related quality of life after cancer occurring among children and adolescents ', European journal of cancer (Oxford, England : 1990), vol. 103, pp. 227-237 . https://doi.org/10.1016/j.ejca.2018.08.007
European Journal of Cancer, 103, 227-237. ELSEVIER SCI LTD
Aims: Survival after cancer diagnosed during childhood or adolescence continues to improve with new treatments and supportive therapies. Optimal long-term care requires that risks to vulnerable organs are clearly defined and translated into guideline
Autor:
T Kepak, Lucia Masárová, Věra Feitová, Jan Máchal, Mary Luz Mojica-Pisciotti, L Opatril, Roman Panovsky, Vladimír Kincl, Tomáš Holeček
Publikováno v:
European Heart Journal. 41
Introduction Due to cardiotoxic treatment, childhood cancer survivors (CCS) are at 15-fold increased risk of developing chronic heart failure and are at 7-fold higher risk of premature death due to cardiac causes compared with the general population.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.